# A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

> **NCT03251118** · — · ACTIVE_NOT_RECRUITING · sponsor: **Target PharmaSolutions, Inc.** · enrollment: 15000 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Crohn's Disease
- Ulcerative Colitis
- Indeterminate Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03251118
- **Lead sponsor:** Target PharmaSolutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-07-24
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 15000 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03251118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03251118, "A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03251118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*